You just read:

2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors

News provided by

CStone Pharmaceuticals

Sep 21, 2019, 21:25 ET